Data is not available at this time.
HORIBA, Ltd. is a diversified technology company specializing in precision measurement and analytical instruments across five key segments: Automotive, Process & Environmental, Medical-Diagnostic, Semiconductor, and Scientific. The company’s core revenue model is built on manufacturing high-end diagnostic and testing systems, serving industries ranging from automotive R&D to semiconductor fabrication and environmental monitoring. Its Automotive segment, a significant revenue driver, provides emission analyzers and test systems critical for compliance with global environmental regulations, positioning HORIBA as a leader in vehicle testing solutions. The Process & Environmental segment addresses industrial and regulatory needs for air and water quality monitoring, while the Medical-Diagnostic segment supports clinical laboratories with hematology and immunology analyzers. HORIBA’s Semiconductor Instruments & Systems segment caters to the high-growth semiconductor industry with precision measurement tools, and its Scientific segment offers advanced spectroscopy and elemental analysis equipment for research institutions. The company’s market position is strengthened by its technological expertise, long-standing customer relationships, and a global footprint, particularly in Asia, Europe, and North America. HORIBA’s diversified portfolio mitigates sector-specific risks while allowing it to capitalize on trends like electrification, environmental sustainability, and semiconductor innovation.
HORIBA reported revenue of JPY 317.4 billion for FY 2024, with net income of JPY 33.6 billion, reflecting a net margin of approximately 10.6%. The company generated JPY 40.3 billion in operating cash flow, demonstrating solid cash conversion efficiency. Capital expenditures of JPY 18.2 billion indicate ongoing investments in R&D and production capabilities, aligning with its focus on high-value instrumentation.
Diluted EPS stood at JPY 795.34, underscoring HORIBA’s earnings resilience despite macroeconomic headwinds. The company’s capital efficiency is evident in its ability to maintain profitability across cyclical segments, supported by recurring revenue from service and maintenance contracts. Its diversified business model helps stabilize earnings, though exposure to semiconductor and automotive cycles introduces some volatility.
HORIBA maintains a robust balance sheet with JPY 144.3 billion in cash and equivalents, against total debt of JPY 64.4 billion, indicating a conservative leverage profile. The strong liquidity position provides flexibility for strategic acquisitions or organic growth initiatives, while the manageable debt level ensures financial stability even in downturns.
Growth is driven by demand for emission testing systems, semiconductor tools, and medical diagnostics, though cyclicality in these sectors may lead to uneven performance. The company’s dividend per share of JPY 105 reflects a commitment to shareholder returns, supported by consistent cash flow generation. Future growth may hinge on expansion in emerging markets and technological advancements in its core segments.
With a market capitalization of JPY 420.2 billion and a beta of 1.47, HORIBA is viewed as moderately volatile relative to the broader market. Investors likely price in its exposure to high-growth sectors like semiconductors and environmental tech, balanced by its established position in stable industries such as medical diagnostics and automotive testing.
HORIBA’s key advantages include its technological leadership in precision measurement, a diversified customer base, and strong R&D capabilities. The outlook remains positive, supported by regulatory tailwinds in emissions control and semiconductor manufacturing. However, competition and supply chain risks could pose challenges. Strategic focus on innovation and global expansion will be critical to sustaining long-term growth.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |